Related references
Note: Only part of the references are listed.YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BIOESSAYS (2020)
TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells
Sofia M. E. Weiler et al.
CANCER LETTERS (2020)
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz
Andrea Bisso et al.
HEPATOLOGY (2020)
Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways
Boon C. Heng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats
Alessandro Sammarco et al.
VETERINARY PATHOLOGY (2020)
Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF- signaling pathways in carbon tetrachloride (CCl4)-induced liver fibrosis in rats
Roohollah Mohseni et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Matthias Van Haele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
Hyuk Moon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury
Lara Planas-Paz et al.
CELL STEM CELL (2019)
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration
Brian J. Pepe-Mooney et al.
CELL STEM CELL (2019)
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Andrew J. Haak et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer
Ning Sheng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma
Wantae Kim et al.
GUT (2018)
Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1 signaling
Chenxi Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
Shanshan Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Federica Lo Sardo et al.
CANCERS (2018)
Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours
Charlene Rico et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
An evaluation of TAZ and YAP crosstalk with TGF signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression
Anita K. Luu et al.
BMC VETERINARY RESEARCH (2018)
NUAK2 is a critical YAP target in liver cancer
Wei-Chien Yuan et al.
NATURE COMMUNICATIONS (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
Regulation of Hippo signaling by actin remodeling
Jimyung Seo et al.
BMB REPORTS (2018)
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Wantae Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors
Samantha Guillemette et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2017)
The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy
Maoxu Ge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ
Tito Panciera et al.
Cell Stem Cell (2016)
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Ximena Bonilla et al.
NATURE GENETICS (2016)
A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours
G. Beffagna et al.
VETERINARY JOURNAL (2016)
LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development
Da-Hye Lee et al.
NATURE COMMUNICATIONS (2016)
Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
Matthieu Corvaisier et al.
ONCOTARGET (2016)
ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
Kun Zhang et al.
SCIENTIFIC REPORTS (2016)
Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway
Sun-Yong Kim et al.
SCIENTIFIC REPORTS (2016)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer
Satoshi Noguchi et al.
CLINICAL CANCER RESEARCH (2014)
Pro-tumorigenic Effects of Transforming Growth Factor Beta 1 in Canine Osteosarcoma
R. F. Portela et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression
Laura M. Koontz et al.
DEVELOPMENTAL CELL (2013)
Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
Darjus Felix Tschaharganeh et al.
GASTROENTEROLOGY (2013)
The Hippo pathway: regulators and regulations
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
The regulation and function of the NUAK family
Xianglan Sun et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Upstream regulators of the Hippo pathway
Fa-Xing Yu et al.
CELL CYCLE (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Improving the analysis of quantitative PCR data in veterinary research
Stephen Bustin et al.
VETERINARY JOURNAL (2012)
The Hippo pathway and apico-basal cell polarity
Alice Genevet et al.
BIOCHEMICAL JOURNAL (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Hippo pathway regulation by cell morphology and stress fibers
Ken-Ichi Wada et al.
DEVELOPMENT (2011)
From one medicine to one health and systemic approaches to health and well-being
J. Zinsstag et al.
PREVENTIVE VETERINARY MEDICINE (2011)
MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments
Stephen A. Bustin et al.
BMC MOLECULAR BIOLOGY (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Efficacy of Antivascular Photodynamic Therapy Using Benzoporphyrin Derivative Monoacid Ring A (BPD-MA) in 14 Dogs with Oral and Nasal Tumors
Tomohiro Osaki et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2009)
SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila
Youlian Goulev et al.
CURRENT BIOLOGY (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
A validation of 10 feline reference genes for gene expression measurements in snap-frozen tissues
Louis C. Penning et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2007)
Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies
Iain R. Peters et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2007)
Development and evaluation of canine reference genes for accurate quantification of gene expression
Bas Brinkhof et al.
ANALYTICAL BIOCHEMISTRY (2006)
Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation
Bernard A. Callus et al.
FEBS JOURNAL (2006)
Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms
T Osaki et al.
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE (2006)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
Control of cell proliferation and apoptosis by Mob as tumor suppressor, Mats
ZC Lai et al.
CELL (2005)
The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis
JH Jia et al.
GENES & DEVELOPMENT (2003)
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis
KF Harvey et al.
CELL (2003)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines
N Tapon et al.
CELL (2002)
Photodynamic therapy using verteporfin (benzoporphyrin derivative monoacid ring A, BPD-NU) and 630 nm laser light in canine esophagus
M Panjehpour et al.
LASERS IN SURGERY AND MEDICINE (2002)
Share Paper
